Morningstar Investment Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.68M | Buy |
|
|||||
|
2024
Q2 | $1.9M | Buy |
|
|||||
|
2024
Q1 | $1.99M | Sell |
|
|||||
|
2023
Q4 | $4.33M | Buy |
|
|||||
|
2023
Q3 | $1.9M | Buy |
|
|||||
|
2023
Q2 | $1.85M | Buy |
|
|||||
|
2023
Q1 | $1.82M | Buy |
|
|||||
|
2022
Q4 | $1.88M | Buy |
|
|||||
|
2022
Q3 | $1.52M | Sell |
|
|||||
|
2022
Q2 | $1.58M | Buy |
|
|||||
|
2022
Q1 | $1.18M | Buy |
|
|||||
|
2021
Q4 | $1.1M | Buy |
|
|||||
|
2021
Q3 | $792K | Buy |
|
|||||
|
2021
Q2 | $777K | Buy |
|
|||||
|
2021
Q1 | $575K | Buy |
|
|||||
|
2020
Q4 | $317K | Sell |
|
|||||
|
2020
Q3 | $278K | Buy |
|
|||||
|
2020
Q2 | $430K | Sell |
|
|||||
|
2020
Q1 | $295K | Buy |
|
|||||
|
2019
Q4 | $294K | Sell |
|
|||||
|
2019
Q3 | $253K | Sell |
|
|||||
|
2019
Q2 | $337K | Sell |
|
|||||
|
2019
Q1 | $387K | Sell |
|
|||||
|
2018
Q4 | $425K | Sell |
|
|||||
|
2018
Q3 | $490K | Buy |
|
|||||
|
2018
Q2 | $426K | Buy |
|
|||||
|
2018
Q1 | $352K | Buy |
|
|||||
|
2017
Q4 | $365K | Sell |
|
|||||
|
2017
Q3 | $393K | Sell |
|
|||||
|
2017
Q2 | $391K | Sell |
|
|||||
|
2017
Q1 | $382K | Buy |
|
|||||
|
2016
Q4 | $246K | Buy |
|
|||||
|
2016
Q3 | $268K | Buy |
|